Home
/ Moderna
/ Competitors

Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include CureVac and Regulus Therapeutics.

	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date	Founding Date 2010	Founding Date 2000	Founding Date 2007
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations San Diego, US HQ
Employees	Employees 5,60044% increase	Employees 999	Employees 2462% decrease
Valuation ($)	Valuation ($) 21.2 b	Valuation ($) 648.3 m	Valuation ($) 105.4 m
Financial
Revenue (est.)	Revenue (est.) $3.2b (FY, 2024)	Revenue (est.) €53.8m (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods $1.5b (FY, 2024)	Cost of goods €64.3m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit $1.8b (FY, 2024)	Gross profit (€2.6m) (FY, 2023)	Gross profit N/A
Net income	Net income ($3.6b) (FY, 2024)	Net income (€260.2m) (FY, 2023)	Net income ($46.4m) (FY, 2024)
Operating ⚠
Patent Applications	Patent Applications 430 (FY, 2021)	Patent Applications 500 (Mar, 2020)	Patent Applications N/A
Patents Issued	Patents Issued 270 (FY, 2020)	Patents Issued 233 (May, 2020)	Patents Issued 300 (FY, 2016)
Funding
Total funding raised	Total funding raised $ 1.8b	Total funding raised $ 1.1b	Total funding raised $ 10m